Role of MAPK in chronic cerebral vasospasm

K Aoki1, A Y Zubkov, R E Tibbs

  • 1Department of Neurosurgery, University of Mississippi Medical Center, Jackson 39216-4505, USA.

Life Sciences
|May 15, 2002
PubMed

Insights

p44/42 mitogen-activated protein kinase (MAPK) plays a key role in subarachnoid hemorrhage (SAH)-induced cerebral vasospasm. MEK inhibitor PD98059 effectively reversed this vasospasm in a canine model.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Subarachnoid hemorrhage (SAH) can lead to delayed cerebral vasospasm, a significant cause of morbidity and mortality.
  • The precise molecular mechanisms underlying SAH-induced vasospasm are not fully understood.

Purpose of the Study:

  • To investigate the involvement of p44/42 mitogen-activated protein kinase (MAPK) in canine SAH.
  • To determine if MEK inhibitors can mitigate SAH-induced cerebral vasoconstriction.

Main Methods:

  • A double hemorrhage model of SAH was established in dogs.
  • Basilar artery diameter was measured via angiogram over 7 days.
  • p44/42 MAPK levels were assessed using immunoprecipitation.
  • The effect of MEK inhibitor PD98059 on vasospasm and MAPK levels was evaluated.

Main Results:

  • SAH induced a time-dependent decrease in basilar artery diameter, indicative of vasospasm.
  • p44/42 MAPK levels significantly increased following SAH and remained elevated.
  • PD98059 treatment significantly reduced p44/42 MAPK activation.
  • PD98059 administration significantly reversed vasospasm, increasing residual basilar artery diameter.

Conclusions:

  • p44/42 MAPK signaling is implicated in the pathogenesis of cerebral vasospasm after SAH.
  • MEK inhibitor PD98059 demonstrates therapeutic potential for treating SAH-induced vasospasm.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...